Endo (NDOI) Total Stockholders Equity : $1,252 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Total Stockholders Equity?

Endo's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $1,252 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Endo's Book Value per Share for the quarter that ended in Dec. 2024 was $16.43. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Endo's Debt-to-Equity for the quarter that ended in Dec. 2024 was 1.98.

Endo Total Stockholders Equity Historical Data

The historical data trend for Endo's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Total Stockholders Equity Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Total Stockholders Equity

-6,597.56

1,252.34

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial			-	-6,597.56	-	1,600.56	1,252.34

Endo (OTCPK:NDOI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Endo's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1252.338	-	0)	/	76.211
	=	16.43

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Endo's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.994	+	2457.48)	/	1252.338
	=	1.98

Endo Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Endo's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.